Product correctly added to cart.

discount label
Nornalmefene
View 3D

Biosynth logo

Nornalmefene

CAS: 42971-33-5

Ref. 3D-SBA97133

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 16 Jul 2024

Product Information

Name:
Nornalmefene
Controlled Product
Description:

Nornalmefene is a synthetic opioid receptor antagonist that blocks the binding of opioid drugs to the mu and kappa receptors. It is used in the treatment of alcohol dependence. The pharmacokinetic properties of nalmefene are similar to other oral medications, with a half-life of approximately 10 hours. Nornalmefene has been shown to be safe and effective in humans when taken orally and has potential use as a chronic oral therapy for alcoholism. Nalmefene binds to the mu and kappa opioid receptors, which are involved in pain signaling pathways, modulating the effects of opioids such as morphine. Nalmefene also decreases craving for alcohol by inhibiting dopamine release in the nucleus accumbens, an area of the brain involved in addiction.
Nalmefene undergoes metabolism in vivo by CYP3A4 and CYP2D6 enzymes into its active form naloxone, which is responsible for its antagonistic effects on opioid receptors. Active metabolites are

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
285.34 g/mol
Formula:
C17H19NO3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-SBA97133 Nornalmefene

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".